Everest Organics Ltd

BSE
BUY

1W Return

1M Return

6M Return

1Y Return

3Y Return

Start SIP in Everest Organics Ltd
Stock Performance
52 Week Low - High
Today’s Low - High

Open

Prev. Close

Total Traded Value

View details of Market Depth
Fundamental

Market Cap (in crs)

Face Value

Turnover (in lacs)

Key Metrics
Qtr Change %
35.02% Gain from 52W Low
-11.2
TTM PE Ratio
High in industry
539.9
Price to Book Ratio
Below industry Median
2.3
Dividend yield 1yr %
0
TTM PEG Ratio
PEG TTM is less than 1
0.2
RSI
RSI is mid-range
53.8
MFI
MFI Overbought
77.1

Everest Organics Ltd shareholding Pattern

Promoter
74.2%
Public
25.8%
Promoter
74.2%
Public
25.8%
Promoter
74.2%
Public
25.8%
Promoter
74.2%
Public
25.8%
Promoter
74.2%
Public
25.8%
Promoter
74.2%
Public
25.8%

Everest Organics Ltd Technical Analysis

Moving Averages Analysis
Moving Averages Analysis
Current Price
Bullish Moving Averages
13
Bearish Moving Averages
3
5Day EMA
131.80
10Day EMA
130.70
12Day EMA
130.30
20Day EMA
129.10
26Day EMA
128.90
50Day EMA
129.50
100Day EMA
129.50
200Day EMA
127.60
5Day SMA
132.50
10Day SMA
130.60
20Day SMA
128.60
30Day SMA
125.80
50Day SMA
128.70
100Day SMA
132.90
150Day SMA
128.80
200Day SMA
126.70
Delivery & Volume
Resistance & Support
131.82
Pivot
Resistance
First Resistance
132.63
Second Resistance
134.27
Third Resistance
135.08
Support
First Support
130.18
Second support
129.37
Third Support
127.73
Relative Strength Index
53.75
Money Flow Index
77.06
MACD
1.41
MACD Signal
0.58
Average True Range
7.16
Average Directional Index
28.68
Rate of Change (21)
7.60
Rate of Change (125)
11.73
Peer comparison
Compare
Company
Market Price
Market Cap
52W Low
52W High
Makers Laboratories Ltd.
-
-
-
Biofil Chemicals & Pharmaceuticals Ltd.
110.12
41.01
78.8
Everest Organics Ltd.
-
-
-
Sunil Healthcare Ltd.
-
-
-
Mercury Laboratories Ltd.
-
-
-
Chandra Bhagat Pharma Ltd.
-
-
-
Zenith Drugs Ltd.
-
-
-

Everest Organics Ltd Company background

Founded in: 1993
Managing director: Srikakarlapudi Sirisha
Everest Organics Ltd was incorporated at Hyderabad in Feb.93. It was promoted by S K Srihari Raju and S K Chittiramabhadra Raju. The Company is engaged in manufacturing of Active Pharmaceutical Ingredients and their intermediaries. The Company commenced its commercial operations in the year 1993. It set up a plant at Aroor, Andhra Pradesh to manufacture bulk drugs and formulations. It came out with a public issue in Jan.95 to partfinance the project.Commercial production of ciprofloxacin and omerprazole commenced in Feb.96. The company preferred to manufacture para hydroxy phynyl glycin (PHPG), but due to market conditions, it decided to drop manufacturing of PHPG and has decided to enhance the capacity of ciprofloxacin from 30 tpa to 120 tpa and also to manufacture enrofloxacin/naproxen.The company increased its installed capacity of Benzimidazole by 60 tpa there by taking its capacity to 120 tpa. The installed capacity of Omeprazole Op Sulphide was increased from 15 TPA to 30 TPA. It introduced one more new product by name Esomeprazole Magnesium by creating additional facility by making investment in plant machinery in 200708.
Read More

Everest Organics Ltd FAQs

You can easily buy Everest Organics Ltd shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.

Open Demat Account
or Resume your Application
+91 -

personImage